Overview

Gabapentin Alone and in Combination With Carvedilol for the Treatment of Rosacea-Associated Flushing and Erythema:a Randomized Controlled Clinical Trial

Status:
COMPLETED

Trial end date:
2025-01-06

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to learn if Gabapentin works to treat flushing/erythema associated with rosacea. It will also learn about the safety of drug Gabapentin. The main questions it aims to answer are: * Does drug Gabapentin reduce flushing and erythema associated with rosacea? * What medical problems do participants have when taking drug Gabapentin? Researchers will compare Gabapentin to a positive control (minocycline plus hydroxychloroquine, a first-line treatment for rosacea) to see if drug Gabapentin works to reduce flushing and erythema associated with rosacea

Phase:

PHASE1

Details

Lead Sponsor:

First Affiliated Hospital of Chongqing Medical University

Treatments:

BID protein, human
Gabapentin
Hydroxychloroquine